Hisamitsu Pharmaceutical Co., Ltd.
 
 
 
 
公司概覽
業務類別 --
業務概覽 Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
公司地址 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
電話號碼 +81 942832101
傳真號碼 +81 942836119
公司網頁 https://www.hisamitsu.co.jp
員工數量 3697
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Kazuhide Nakatomi Director, President and Chief Executive Officer -- 23/05/2025
Mr. Kyu Saito Director, Managing Director, Executive Officer and Head of Global Business Strategy; Chairman of the Board of Hisamitsu Pharmaceutical Co Inc and President of Subsidiaries -- 23/05/2025
Mr. Nobuo Tsutsumi Director and Executive Officer -- 23/05/2025
Mr. Shinichi Murayama Director and Executive Officer -- 23/05/2025
Mr. Koji Takiyama Director and Executive Officer -- 23/05/2025
 
董事會成員
董事會 職務 更新日期
Ms. Midori Noguchi Independent Director 23/05/2025
Ms. Tamako Watanabe Independent Director 23/05/2025
Mr. Kazuhide Nakatomi Director, President and Chief Executive Officer 23/05/2025
Mr. Kyu Saito Director, Managing Director, Executive Officer and Head of Global Business Strategy; Chairman of the Board of Hisamitsu Pharmaceutical Co Inc and President of Subsidiaries 23/05/2025
Mr. Nobuo Tsutsumi Director and Executive Officer 23/05/2025
Mr. Shinichi Murayama Director and Executive Officer 23/05/2025
Mr. Yuichiro Anzai Independent Director 23/05/2025
Mr. Yuichi Isobe Director 23/05/2025
Mr. Tetsugo Matsuo Independent Director 23/05/2025
Mr. Koji Takiyama Director and Executive Officer 23/05/2025
 
所屬ETF (更新日期: 07/03/2026 02:38)
代號 名稱 佔比% 持有日期
IEFAiShares Core MSCI EAFE ETF0.19%28/02/2026
VIGIVanguard Intl Div Apprec ETF0.18%31/01/2026
VEUVanguard FTSE All-Wld ex-US ETF0.17%31/01/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.12%28/02/2026
SCZiShares MSCI EAFE Small-Cap ETF0.10%28/02/2026
SCHFSchwab International Equity ETF™0.07%28/02/2026
FNDCSchwab Fundamental International SmEqETF0.07%28/02/2026
VTVanguard Total World Stock ETF0.06%31/01/2026
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.03%27/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF0.02%28/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.01%24/02/2026
IPACiShares Core MSCI Pacific ETF0.01%28/02/2026
SCJiShares MSCI Japan Small-Cap ETF0.01%28/02/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.005%27/02/2026
WSMLiShares MSCI World Small-Cap ETF0.002%28/02/2026
DEEFXtrackers FTSE Develop ex US Mulfact ETF0.001%24/02/2026
FLJHFranklin FTSE Japan Hedged ETF0.001%28/02/2026
PBDMInvesco PureBeta FTSE Dev ex-NrthAmr ETF0.00004%31/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.